Thanks to a collaboration between the Office of the Maricopa County School Superintendent and the Flinn Foundation, Arizona Bioscience Week will be celebrated in classrooms across Arizona as teachers and students explore pathways to life science and bioscience careers.Continue reading
Category Archives: AZBio News
Illumina Ventures Announces New Partner, Mara Aspinall, Has Joined Its Investment Team
San Francisco, CA — September 21, 2023 — Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner.
Continue reading
Dr. Potts Goes to Washington
AZBio Board Member Dr. Steve Potts was in Washington, D.C. on Wednesday, September 20, 2023. He testified in the Subcommittee on Oversight and Investigations of the House Energy and Commerce Committee on how the Inflation Reduction Act’s price setting provisions are already raising the hurdles for health innovators as they race to develop new small molecule treatments and cures. Continue reading
HonorHealth Research Institute clinical trial helps secure FDA approval of revolutionary new pacemaker
SCOTTSDALE, Ariz. — Sept. 19, 2023 — HonorHealth Research Institute is ushering in a new era of heart pacemakers for patients with abnormal or slow heart rhythms by helping secure FDA approval of the world’s first dual chamber leadless pacemaker.Continue reading
Cancer Caregivers of America Launches Online Cancer Caregivers Educational Platform
Comprehensive online program allows patients, caregivers, and families education, tools, and support systems specific to caring for cancer patients of all kinds.Continue reading
Ceria Therapeutics, Inc. Awarded a $2,100,000 SBIR Grant to Advance Development of a Novel Treatment for Acute Lung Injuries, Acute Lung Failure, and Acute Respiratory Distress Syndrome
The award will go towards the development of CTX-002 in preparation for clinical studiesContinue reading
C-Path and EATRIS Join Forces with New Collaboration Agreement
AMSTERDAM and TUCSON, Ariz., September 18, 2023 — Critical Path Institute (C-Path) and EATRIS (the European Research Infrastructure for Translational Medicine) are pleased to announce the signing of a collaboration agreement aimed at fostering actionable scientific and educational cooperation. Continue reading
Drug Discovery Summit catalyst for new approaches and therapies
Academic researchers and industry professionals will discuss drug development at the Fifth Annual Arizona Drug Discovery and Development Summit during Arizona Bioscience WeekContinue reading
Jazz Pharmaceuticals Announces Key Update to Leadership Team
Renée Galá promoted to President and Chief Operating Officer
National Institutes of Health To Locate Signature Research Program on the Phoenix Bioscience Core
PHOENIX (September 14, 2023) – Wexford Science & Technology, LLC today announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This innovative basic, translational, and clinical research center will occupy the entire 7th floor of 850 PBC, comprising approximately 35,000 square feet.Continue reading